Latest News about ALLO
Recent news which mentions ALLO
From Benzinga
From Benzinga
From Benzinga
From Benzinga
Allogene's Preclinical Data Show Healthy Donor-Derived Allogeneic CAR T Cells Have Better Immune Fitness, Killing Activity
March 23, 2022
From Benzinga
Why Cellectis Stock Rose 20.7% This Week
March 10, 2022
From Motley Fool
Stocks That Hit 52-Week Lows On Wednesday
February 16, 2022
From Benzinga
FDA Lifts Clinical Hold On Allogene's CAR-T Trials
January 11, 2022
From Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
December 20, 2021
From Benzinga
58 Biggest Movers From Yesterday
December 14, 2021
From Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
December 13, 2021
From Benzinga
The Week Ahead In Biotech (Dec. 12-18): Hematology Conference Presentations, FDA Decisions For Calliditas, Argenx, Intra-Cellular & Eagle Pharma And More
December 12, 2021
From Benzinga
Being First Is Not Enough For Crispr Therapeutics
November 15, 2021
From InvestorPlace
Cathie Wood's Buying Beam Therapeutics -- Should You?
November 09, 2021
From Motley Fool
Allogene Therapeutics Inc (ALLO) Q3 2021 Earnings Call Transcript
November 05, 2021
Tickers
ALLO
From Motley Fool
The Daily Biotech Pulse: Merck's Oral COVID-19 Pill Authorized In UK, Novartis Cashes Out Of Roche, Chimerix Plunges On Data, Evotec IPO
November 04, 2021
From Benzinga
The Week Ahead In Biotech (Oct. 31-Nov. 6): Earnings Pick Up Pace, Eton Awaits Seizure Drug Approval, Kidney Conference, More IPOs In The Pipeline
October 31, 2021
From Benzinga
2 Top Healthcare Stocks That Could Be Bought Out in 2022
October 16, 2021
From Motley Fool
Why Shares of Allogene Therapeutics, Beam Therapeutics, Intellia Therapeutics, and Schrödinger Are Volatile This Week
October 15, 2021
From Motley Fool
50 Biggest Movers From Yesterday
October 14, 2021
From Benzinga
What 5 Analyst Ratings Have To Say About Allogene Therapeutics
October 12, 2021
Tickers
ALLO
From Benzinga
The Daily Biotech Pulse: NRx Stitches COVID-19 Drug Partnership, Protara Gets Nod For Starting Bladder Cancer Study, IGM Moves Beyond Oncology
October 12, 2021
From Benzinga
Cathie Wood Goes Dumpster Diving: 3 Sagging Stocks She Just Bought
October 12, 2021
From Motley Fool
35 Biggest Movers From Friday
October 11, 2021
From Benzinga
The Week Ahead In Biotech (Oct. 10-16): Avadel FDA Decision, Conference Presentations And IPOs Take Center Stage
October 10, 2021
From Benzinga
Mid-Afternoon Market Update: Dow Surges 80 Points; ChemoCentryx Shares Spike Higher
October 08, 2021
From Benzinga
From Motley Fool
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
|
|
|